Do Ozempic and Mounjaro cause depression or suicidal thoughts? A new systematic review of 20 studies plus EMA and FDA assessments says the best evidence doesn't show it. Randomized data, including two large 2025 meta-analyses, found no increased suicidality, depression, or anxiety with semaglutide or tirzepatide. The scarier signals came from study designs that can't separate drug effects from obesity-related distress, baseline psychiatric risk, and reporting bias. But trials excluded many psychiatric patients, so surveillance still matters for high-risk groups and rare long-term outcomes.
This page is available in